americangene.comHealthcareFounded: 2007Funding to Date: $72.88MM
American Gene Technologies ("AGT") is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including large and orphan indications, infectious disease, immune-oncology, and monogenic disorders.
View Enterprise Value for American Gene Technologies International.